Association between cardiovascular disease- and inflammation-related serum biomarkers and poor lung function in elderly

[1] Vogelmeier CF(2017)Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary Am J Respir Crit Care Med 195 557-82

[2] Criner GJ(2019)Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies BMJ Open 9 e028150-1343

[3] Martinez FJ(2012)Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations Eur Respir J 40 1324-1277

[4] Anzueto A(2005)Interpretative strategies for lung function tests Eur Respir J 26 948-s345

[5] Barnes PJ(2011)Recommendations for epidemiological studies on COPD Eur Respir J 38 1261-36

[6] Bourbeau J(2000)Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition Chest 117 339s-874

[7] Thomas ET(2007)COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study Chest 131 29-127

[8] Guppy M(2012)The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands Respir Med 106 871-122

[9] Straus SE(2012)The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden–the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study Clin Respir J 6 120-472

[10] Bell KJL(2020)Decreased COPD prevalence in Sweden after decades of decrease in smoking Respir Res 21 283-10

[1] Vogelmeier CF(2017)Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary Am J Respir Crit Care Med 195 557-82

[2] Criner GJ(2019)Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies BMJ Open 9 e028150-1343

[3] Martinez FJ(2012)Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations Eur Respir J 40 1324-1277

[4] Anzueto A(2005)Interpretative strategies for lung function tests Eur Respir J 26 948-s345

[5] Barnes PJ(2011)Recommendations for epidemiological studies on COPD Eur Respir J 38 1261-36

[6] Bourbeau J(2000)Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition Chest 117 339s-874

[7] Thomas ET(2007)COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study Chest 131 29-127

[8] Guppy M(2012)The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands Respir Med 106 871-122

[9] Straus SE(2012)The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden–the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study Clin Respir J 6 120-472

[10] Bell KJL(2020)Decreased COPD prevalence in Sweden after decades of decrease in smoking Respir Res 21 283-10